Digital ILC 2020

This year, at the Digital International Liver Congress 2020, FIND and the Burnet Institute are presenting on the Hepatitis C: Community-based Testing and Treatment Study (CT2 Study) which was designed to assess the feasibility and acceptability of a decentralized ‘one-stop-shop’ hepatitis C care model in Myanmar.

The ‘one-stop-shop’ model of care for hepatitis C means patients are only required to attend one site for getting a blood sample, hepatitis C testing and counselling, consultations with medical staff, treatment dispensing and assessment of treatment outcome. The CT2 Study was implemented by the Burnet Institute and Myanmar Liver Foundation, in partnership with FIND, as part of the Unitaid-funded HEAD-Start Projects.

Abstract title: Community-based point-of-care hepatitis C testing and general practitioner-initiated direct-acting antiviral therapy in Yangon, Myanmar

Date & time: 28 August 2020, 15:30–15:45 CEST


On Saturday, 29 August 2020, from 9:30–19:30, FIND is presenting three posters:

  Poster title Presenter
SAT-346 Demonstration of the feasibility of two innovative models of HCV testing & treatment in two unique populations in Punjab and Delhi, India-HEAD-Start project Preetishirin Katapur, FIND
SAT-353 The HEAD-Start project: introduction of rapid diagnostic tests for hepatitis C screening in primary healthcare sites as a first step towards decentralizing hepatitis C care in Malaysia Xiao Hui Sem, FIND
SAT-374 Decentralizing HCV testing to harm reduction sites; HEAD-Start Georgia Maia Japaridze, FIND